This poster, presented at ASCO Quality Care 2022, features an analysis of responses entered by healthcare professionals into an online treatment decision support tool for management of adverse events associated with CDK4/6, PI3K, and mTOR inhibitors in hormone receptor–positive breast cancer.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.